Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis
Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis.
Congenital hypomyelinating neuropathy due to the association of a truncating mutation in PMP22 with the classical HNPP deletion.
Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
Pediatric idiopathic transverse myelitis presenting as an anterior cord syndrome: A case report.
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model.
The change in the sex ratio in multiple sclerosis is driven by birth cohort effects.
Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
Walk them or no leg to stand on! Diagnostic delay of neurologic conditions in young children.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.
High-resolution Transcriptome Analysis Reveals Neuropathic Pain Gene- Expression Signatures in Spinal Microglia Following Nerve Injury.
Interim Report Released on Real-World Safety of Fingolimod for Relapsing MS
A multi-time-point modality-agnostic patch-based method for lesion filling in multiple sclerosis.
Capillary telangiectasia mimicking an active demyelinating lesion in a patient with multiple sclerosis.
Adaptive vs. non-adaptive cognitive training by means of a personalized App: a randomized trial in people with multiple sclerosis.
Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
[A young woman with central facial nerve palsy].
Safety of Striatal Infusion of siRNA in a Transgenic Huntington's Disease Mouse Model.
Health Care Resource Utilization Associated with Pediatric Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Immune recognition of citrullinated epitopes.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.
Mediterranean diet adherence and risk of multiple sclerosis: a case-control study.
Pages
« first
‹ previous
…
729
730
731
732
733
734
735
736
737
…
next ›
last »